3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy (Q44457429)
Jump to navigation
Jump to search
scientific article published in June 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy |
scientific article published in June 2003 |
Statements
1 reference
3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy (English)
1 reference
1 reference
Lorna Piazzi
1 reference
Angela Rampa
1 reference
Alessandra Bisi
1 reference
Silvia Gobbi
1 reference
Federica Belluti
1 reference
Andrea Cavalli
1 reference
Piero Valenti
1 reference
Maurizio Recanatini
1 reference
1 June 2003
1 reference
1 reference
46
1 reference
12
1 reference
2279-2282
1 reference
Identifiers
1 reference
1 reference